ArticleHeart and vessels2026
Respiratory stability time and heart failure severity.
Article in Heart and vessels, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel telemonitoring system utilizing contactless sensor technologies combined with automated overnight respiratory stability time (RST) analysis has emerged as a sensitive and specific indicator of early deteriorating heart failure (HF). However, the association between RST and clinical parameters, including hemodynamics, remains unclear. Patients admitted to our institute due to worsening HF between February and December 2025 and underwent RST monitoring and simultaneous right heart catheterization were enrolled in this study. The relationship between RST and patient characteristics, hemodynamic parameters, and clinical outcomes was retrospectively investigated. A total of 30 patients (median age, 75 years; 70% male) were included. RST was negatively correlated with the number of HF hospitalizations, serum creatinine, plasma B-type natriuretic peptide, pulmonary artery pressure and dose of loop diuretics. During a median follow-up of 178 days, a lower RST (≤ 25 s) group showed a numerically higher cumulative incidence of the composite outcomes of HF readmission and all-cause death compared with the higher RST group (50.6% versus 0%, p = 0.019). Lower RST may reflect heart failure severity, including pulmonary congestion. Further research is warranted to establish the clinical efficacy of RST-guided HF management.
Indexed as
Identifiers
42115310What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.